NVCT
NASDAQ
US
Nuvectis Pharma, Inc. - Common Stock
$7.56
▼ $-0.04
(-0.53%)
Vol 18K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$193.4M
ROE
-141.9%
D/E
0.00
Beta
-0.25
52W
$5–$12
Wall Street Consensus
12 analysts · Apr 20263
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
NERV
Minerva Neurosciences Inc
$28.1M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
FENC
Fennec Pharmaceuticals Inc
$262.9M
KRRO
Korro Bio Inc
$75.4M
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9.5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
ZNTL
Zentalis Pharmaceuticals Inc
$97.5M
MGNX
MacroGenics Inc
$101.8M
CRBU
Caribou Biosciences Inc
$148.6M
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.30 | $-0.31 | $-0.01 |
| Sep 2025 | $-0.25 | $-0.33 | $-0.08 |
| Jun 2025 | $-0.26 | $-0.30 | $-0.04 |
| Mar 2025 | $-0.26 | $-0.27 | $-0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -150.8% | -150.8% | -150.8% | -150.8% | -150.3% | -141.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.66 | 2.66 | 2.66 | 2.66 | 2.70 | 3.07 |
Key Ratios
ROA (TTM)
-90.8%
P/B
10.8
EPS (TTM)
$-1.24
CF/Share
$-1.03
52W High
$11.52
52W Low
$4.54
$4.54
52-Week Range
$11.52
How does NVCT compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NVCT valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
10.8
▲
337%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NVCT profitability vs Biotechnology peers
ROE
-141.9%
▼
111%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-90.8%
▼
94%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
NVCT financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.1
▼
31%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
-0.3
▼
126%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
NVCT fundamentals radar
NVCT
Peer median
Industry
NVCT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NVCT vs peers: key metrics
Latest News
No related news yet